Blog Page 76

Biotech uptick moves into March:
“February went out like a lion in biotechnology as filings for initial public offerings (IPOs) by three companies capped a flurry of activity in the sector. Acadia Pharmaceuticals, Alnylam Pharmaceuticals, and Ark Therapeutics announced filings in the wake of strong openings on Wall Street last month for GTx, Renovis, Corgentech, and DynaVax Technologies.”

Doctors Call for Abbott Boycott on AIDS Price Hike
“A group of AIDS doctors on Tuesday called for a boycott of drugs made by Abbott Laboratories Inc. to protest the company’s recent price hike on an important HIV medicine.”

What makes this case particularly interesting is that the price hike is seen by many as a tactic to make using other company’s AIDS drugs more expensive, as they are typically prescribed with Abbott’s Novir, and compensate for profit shortfalls from the the lower than expected doses of Norvir that are being prescribed.

See also: Kaisernetwork, Natap.org.